SFN and pachyonychia congenita: Consistent with a recent study, oxidative stress and dysfunctional NRF2 underlies the palmoplantar keratoderma disorder pachyonychia congenita associated with K16 mutations, with SFN treatment reducing the aberrant keratinisation in krt16−/− mice28.